Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Silverstone, Ph
and
Greenshaw, Aj
1996.
Section Review Central & Peripheral Nervous Systems: 5-HT3receptor antagonists.
Expert Opinion on Therapeutic Patents,
Vol. 6,
Issue. 5,
p.
471.
Pinelli, Arnaldo
Trivulzio, Silvio
and
Tomasoni, Livio
1997.
Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
European Journal of Pharmacology,
Vol. 340,
Issue. 2-3,
p.
111.
Weinstein, Aviv
Wilson, Sue
Bailey, Jayne
Myles, Judy
and
Nutt, David
1997.
Imagery of craving in opiate addicts undergoing detoxification.
Drug and Alcohol Dependence,
Vol. 48,
Issue. 1,
p.
25.
Buckley, md, Peter F.
1998.
Novel Antipsychotic Medications and the Treatment of Comorbid Substance Abuse in Schizophrenia.
Journal of Substance Abuse Treatment,
Vol. 15,
Issue. 2,
p.
113.
Sell, L. A.
Morris, J.
Bearn, J.
Frackowiak, R. S. J.
Friston, K. J.
and
Dolan, R. J.
1999.
Activation of reward circuitry in human opiate addicts.
European Journal of Neuroscience,
Vol. 11,
Issue. 3,
p.
1042.
Sell, L.A.
Morris, J.S.
Bearn, J.
Frackowiak, R.S.J.
Friston, K.J.
and
Dolan, R.J.
2000.
Neural responses associated with cue evoked emotional states and heroin in opiate addicts.
Drug and Alcohol Dependence,
Vol. 60,
Issue. 2,
p.
207.
Chu, Larry F.
Liang, De-Yong
Li, Xiangqi
Sahbaie, Peyman
D'Arcy, Nicole
Liao, Guochun
Peltz, Gary
and
David Clark, J.
2009.
From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.
Pharmacogenetics and Genomics,
Vol. 19,
Issue. 3,
p.
193.
Rajkumar, Ramamoorthy
and
Mahesh, Radhakrishnan
2010.
Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?.
Journal of Psychopharmacology,
Vol. 24,
Issue. 4,
p.
455.
Becker, Ginger L.
Gerak, Lisa R.
Li, Jun-Xu
Koek, Wouter
and
France, Charles P.
2010.
Precipitated and conditioned withdrawal in morphine-treated rats.
Psychopharmacology,
Vol. 209,
Issue. 1,
p.
85.
Wakim, Judith H.
2012.
Alleviating Symptoms of Withdrawal from an Opioid.
Pain and Therapy,
Vol. 1,
Issue. 1,
Corrêa Filho, João Maria
and
Baltieri, Danilo Antonio
2013.
A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil.
Addictive Behaviors,
Vol. 38,
Issue. 4,
p.
2044.
Lin, Shih‐Ku
2014.
Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.
British Journal of Clinical Pharmacology,
Vol. 77,
Issue. 2,
p.
242.
Fakhfouri, Gohar
Rahimian, Reza
Dyhrfjeld-Johnsen, Jonas
Zirak, Mohammad Reza
Beaulieu, Jean-Martin
and
Witkin, Jeffrey M.
2019.
5-HT3Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface.
Pharmacological Reviews,
Vol. 71,
Issue. 3,
p.
383.
Juza, Radomir
Vlcek, Premysl
Mezeiova, Eva
Musilek, Kamil
Soukup, Ondrej
and
Korabecny, Jan
2020.
Recent advances with 5‐HT3 modulators for neuropsychiatric and gastrointestinal disorders.
Medicinal Research Reviews,
Vol. 40,
Issue. 5,
p.
1593.
Mojtabai, Ramin
Susukida, Ryoko
Farokhnia, Mehdi
Nguyen, Trang Quynh
Dunn, Kelly E.
and
Amin‐Esmaeili, Masoumeh
2024.
Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder.
Addiction,
Vol. 119,
Issue. 10,
p.
1803.
eLetters
No eLetters have been published for this article.